Overview
Jeremy Earl represents a broad range of healthcare organizations, with a focus on managed care legal issues. His clients include health insurers, HMOs, healthcare provider organizations, pharmacy benefit managers and administrative service providers to managed care organizations. Jeremy is a practice area leader for the Managed Care Group.
Clients turn to Jeremy for assistance on diverse transactional matters, including joint ventures, complex service agreements and innovative value-based reimbursement arrangements between health plans and providers or intermediary entities. As the line between health plans and providers continues to blur, Jeremy helps healthcare organizations launch novel managed care arrangements by providing strategic insights into the healthcare marketplace and applicable legal and regulatory requirements.
Jeremy routinely advises clients on complex managed care legal issues, with a focus on requirements affecting commercial health insurance, the Medicare Advantage and Part D programs, and state Medicaid managed care programs. He supports health plan clients on significant regulatory matters and litigation, such as Medicare Advantage risk adjustment compliance and investigations, qui tam actions related to Medicaid managed care program compliance, and class actions related to health plan coverage policies.
Jeremy’s regulatory experience includes several significant managed care transactions, including leading a team as health regulatory counsel to CVS in its $69 billion acquisition of Aetna. Jeremy also represents private equity clients selling, acquiring or investing in managed care companies and other healthcare organizations. He has experience managing the regulatory approval process for managed care transactions, including obtaining insurance department, Medicare Advantage program and state Medicaid agency regulatory approvals.
Jeremy is a frequent speaker at national healthcare industry conferences and has been quoted in trade and national publications, including HealthPayer Intelligence, Modern Healthcare, Managed Care Executive, Business Insurance and Vox.com.
Results
- Represented CVS as lead health counsel in its $69 billion acquisition of Aetna, Inc.
- Represented CVS as lead health counsel in its $8 billion acquisition of Signify Health
- Represented Prime Therapeutics in its $1.35 billion acquisition of Magellan Rx
- Represented Prime Therapeutics in the creation of Synergie Medication Collective, a GPO launched by Blue Cross Blue Shield affiliated companies to negotiate rebates for medical benefit drugs
- Represented Novant Health in its joint venture investment in a Medicare Advantage plan with Cone Health
- Represented Ascension Health in its joint venture investment in a Medicare Advantage plan with Centene Corporation
- Represent RWJBarnabas Health in its joint venture investment in Braven, a Medicare Advantage plan with Horizon BCBS and Hackensack Meridian Health
- Represented a large integrated health system in its direct-to-employer agreement with a fortune 500 company
- Represent multiple Medicare Advantage plans in connection with risk adjustment audits, investigations and compliance matters
- Successfully represented a provider-owned health insurer in a medical loss ratio audit, saving the insurer millions of dollars
- Negotiated and drafted numerous value-based and risk contracts between payors and health systems, providers, ACOs and other value-based care entities
Recognitions
- The Legal 500 US, Leading Lawyer, 2022-2023
- The Best Lawyers in America, Healthcare Law, 2023-2024
- Thomson Reuters, Stand-out Lawyer – independently rated lawyers, 2024
- American Health Lawyers Association, Pro Bono Champion, 2012-2014
Credentials
Education
Duke University School of Law, JD, 2009
University of St. Thomas, BA, summa cum laude, 2006
Admissions
California
District of Columbia
